FCM
TEVA icon

Firestone Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Firestone Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,067
Closed -$50K – 409
2021
Q3 		$50K Hold
5,067
– – 0.02% 235
2021
Q2 		$50K Hold
5,067
– – 0.02% 229
2021
Q1 		$58K Hold
5,067
– – 0.02% 217
2020
Q4 		$49K Hold
5,067
– – 0.02% 219
2020
Q3 		$46K Hold
5,067
– – 0.02% 194
2020
Q2 		$62K Hold
5,067
– – 0.03% 170
2020
Q1 		$46K Hold
5,067
– – 0.02% 186
2019
Q4 		$50K Buy
+5,067
New +$45.2K 0.02% 210

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Firestone Capital Management's TEVA Position: Q4 2021 in Review

Firestone Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 5,067 shares — an estimated $50K sold.

Firestone Capital Management first reported a position in TEVA in Q4 2019 and held it in 8 quarters. The position peaked at $62K in Q2 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Firestone Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Firestone Capital Management sold 5,067 Teva Pharmaceuticals shares in Q4 2021, an estimated $50K.
  • Firestone Capital Management first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • Firestone Capital Management's Teva Pharmaceuticals position peaked at $62K in Q2 2020.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Firestone Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.